Dropout from interim methadone and subsequent comprehensive methadone maintenance

American Journal of Drug and Alcohol Abuse

Volumn 35, Issue 6, 2009, Pages 394-398

  Gryczynski, Jan ^a   Schwartz, Robert ^a   O'Grady, Kevin ^b   Jaffe, Jerome ^a  

^a FRIENDS RESEARCH INSTITUTE   (United States)

^b UNIVERSITY OF MARYLAND   (United States)

Author keywords

Dropout; Interim methadone (IM); Methadone; Motivation; Treatment access

Indexed keywords

COCAINE; METHADONE;

ADULT; ARTICLE; CONTROLLED STUDY; CRIMINAL JUSTICE; FEMALE; FOLLOW UP; HEROIN DEPENDENCE; HUMAN; MAJOR CLINICAL STUDY; MALE; METHADONE TREATMENT; MOTIVATION; PATIENT ASSESSMENT;

EID: 73349135339     PISSN: 00952990     EISSN: 10979891     Source Type: Journal    
DOI: 10.3109/00952990903322865     Document Type: Article

References (25)

1. NIH Consensus Development Panel. Effective medical treatment of opiate addiction. J Am Med Assoc 1998; 280(22):1936-1943.
2. Amato L, Davoli M, Perucci CA, Ferri M, Faggiano F, Mattick RP. An overview of systematic reviews of the effectiveness of opiate maintenance therapies: Available evidence to inform clinical practice and research. J Subst Abuse Treat 2005; 28(4):321-329.
3. Gryczynski J, Schwartz R, O'Grady K, Jaffe J. Treatment entry among individuals on a waiting list for methadone maintenance. Am J Drug Alcohol Abuse 2009; 35:290-294.
4. Friedmann PD, Lemon SC, Stein MD, D'Aunno T. Accessibility of addiction treatment: Results from a national survey of outpatient substance abuse treatment organizations. Health Serv Res 2003; 38(3):887-903.
5. Wenger LD, Rosenbaum M. Drug treatment on demand-Not. J Psychoactive Drugs 1994; 26(1):1-11.
6. Yankovitz SR, Des Jarlais DC, Peyser NP, Drew E, Friedmann P, Trigg HL, Robinson JW. A randomized trial of an interim methadone maintenance clinic. Am J Public Health 1991; 81(9):1185-1191.
7. Schwartz RP, Highfield DA, Jaffe JH, Brady JV, Butler CA, Rouse CO, Callaman JM, O'Grady KE, Battjes RJ. A randomized controlled trial of interim methadone maintenance. Arch Gen Psychiatry 2006; 63(1):102-109.
8. Friedmann P, Des Jarlais DC, Peyser NP, Nichols SE, Drew E, Newman RG. Retention of patients who entered methadone maintenance via an interim methadone clinic. J Psychoactive Drugs 1994; 26(2):217-221.
9. Schwartz RP, Highfield DA, Jaffe JH, Callaman JM, O'Grady KE. A randomized controlled trial of interim methadone maintenance: 10 month follow-up. Drug Alcohol Depend 2007; 86(1):30-36.
10. Booth RE, Corsi KF, Mikulich-Gilbertson SK. Factors associated with methadone maintenance treatment retention among street-recruited injection drug users. Drug Alcohol Depend 2003; 74(2):177-185.
11. Simpson DD, Joe GW, Rowan-Szal GA. Drug abuse treatment retention and process effects on follow-up outcomes. Drug Alcohol Depend 1997; 47(3):227-235.
12. Simpson DD, Joe GW. Motivation as a predictor of early dropout from drug abuse treatment. Psychotherapy 1993; 30(2):357-368.
13. McLellan AT, Cacciola JS, Alterman AI, Rikoon SH, Carise D. The Addiction Severity Index at 25: Origins, contributions, and transitions. Am J Addict 2006; 15(2):113-124.
14. Knight K, Holcom M, Simpson DD. TCU psychosocial functioning and motivation scales: manual on psychometric properties. Ft. Worth, TX: Institute of Behavioral Research, Texas Christian University, 1994. Available at: http://www.ibr.tcu.edu/pubs/datacoll/kk6-srf-95.pdf. Last accessed 12/11/2008.
15. Carey KB, Purnine DM, Maisto SA, Carey MP. Assessing readiness to change substance abuse: A critical review of instruments. Clin Psychol: Science and Practice 1999; 6(3):245-266.
16. De Weert-Van Oene GH, Schippers GM, De Jong CA, Schrijvers GA. Motivation for treatment in substance-dependent patients. Eur Addict Res 2002; 8(1):2-9.
17. Cheng S, Long, JS. Testing for IIA in the multinomial logit model. Sociol Methods Res 2007; 35(4):583-600.
18. Joe GW, Simpson D, Broome KM. Retention and patient engagement models for different treatment modalities in DATOS. Drug Alcohol Depend 1999; 57(2):113-125.
19. Joe GW, Simpson D, Broome KM. Effects of readiness for drug abuse treatment on client retention and assessment of process. Addiction 1998; 93(8):1177-1190.
20. Hiller ML, Knight K, Leukefeld C, Simpson DD. Motivation as a predictor of therapeutic engagement in mandated residential substance abuse treatment. Crim Justice Behav 2002; 29(1):56-75.
21. Simpson DD, Joe GW, Rowan-Szal GA, Greener, JM. Drug abuse treatment process components that improve retention. J Subst Abuse Treat 1997; 14(6):565-572.
22. Joe GW, Simpson DD, Greener JM, Rowan-Szal GA. Integrative modeling of client engagement and outcomes during the first 6 months of methadone treatment. Addict Behav 1999; 24(5):649-659.
23. Simpson DD, Joe GW, Rowan-Szal GA, Greener JM. Client engagement and change during drug abuse treatment. J SubstAbuse 1995; 7(1):117-134.
24. Highfield DA, Schwartz RP, Jaffe JH, O'Grady KE. Intravenous and intranasal heroin-dependent treatment-seekers: characteristics and treatment outcome. Addiction 2007; 102(11):1816-1823.
25. Reisinger HS, Schwartz RP,Mitchell SG, Peterson JA, Kelly SM, O'Grady KE, Marrari EA, Brown BS, Agar MH. Premature discharge from methadone treatment: Patient perspectives. J Psychoactive Drugs; in press.